Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1618-7601
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective ; day:3 ; month:2 ; year:2022 ; pages:1-11
The European journal of health economics ; (3.2.2022), 1-11
- Urheber
-
Zinzi, Daniela
Vlachaki, Ioanna
Falla, Edel
Mantopoulos, Theo
Nathwani, Dilip
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10198-022-01432-2
- URN
-
urn:nbn:de:101:1-2022051219123091592994
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zinzi, Daniela
- Vlachaki, Ioanna
- Falla, Edel
- Mantopoulos, Theo
- Nathwani, Dilip
- SpringerLink (Online service)
Ähnliche Objekte (12)
Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Correction to: Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department
Financial Analysis of Dalbavancin for Acute Bacterial Skin and Skin Structure Infections for Self-Pay Patients
Bacterial cell-free metabolites-based zinc oxide nanoparticles for combating skin-causing bacterial infections
Oritavancin (KIMYRSA™) in acute bacterial skin and skin structure infections: a profile of its use in the USA
Bestatin in the treatment of chronic reoccurring bacterial infections of the skin
Peculiar evolution of streptococcal skin infections
Bacterial Skin Dysbiosis in Darier Disease
Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial
A Multicenter Evaluation of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections
Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis
Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Correction to: Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department
Financial Analysis of Dalbavancin for Acute Bacterial Skin and Skin Structure Infections for Self-Pay Patients
Bacterial cell-free metabolites-based zinc oxide nanoparticles for combating skin-causing bacterial infections
Oritavancin (KIMYRSA™) in acute bacterial skin and skin structure infections: a profile of its use in the USA
Bestatin in the treatment of chronic reoccurring bacterial infections of the skin
Peculiar evolution of streptococcal skin infections
Bacterial Skin Dysbiosis in Darier Disease
Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial
A Multicenter Evaluation of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections
Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis
Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Correction to: Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department
Financial Analysis of Dalbavancin for Acute Bacterial Skin and Skin Structure Infections for Self-Pay Patients
Bacterial cell-free metabolites-based zinc oxide nanoparticles for combating skin-causing bacterial infections
Oritavancin (KIMYRSA™) in acute bacterial skin and skin structure infections: a profile of its use in the USA
Bestatin in the treatment of chronic reoccurring bacterial infections of the skin
Peculiar evolution of streptococcal skin infections
Bacterial Skin Dysbiosis in Darier Disease
Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial
A Multicenter Evaluation of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections